Underestimated, Underdiagnosed and Undertreated
Analyzes the disease, symptoms and consequences and risk factors. Provides detailed estimates of prevalence and the percentage of patients diagnosed and treated.
Projects growth of the PAD market with the ageing population through 2020. Discusses pharmaceutical treatments by therapeutic category and provides PAD market estimates for each for the years 2000, 2002 and through 2020.
Includes information and financial data pages for the 26 companies with products currently marketed in the U.S.